78 related articles for article (PubMed ID: 3932490)
1. Expression of interleukin 2 receptor on Hodgkin's and non-Hodgkin's lymphomas and macrophages.
Schwarting R; Gerdes J; Stein H
J Clin Pathol; 1985 Oct; 38(10):1196-7. PubMed ID: 3932490
[No Abstract] [Full Text] [Related]
2. The nature of the Hodgkin cell. Report of the First International Symposium on Hodgkin's Lymphoma, Köln, Federal Republic of Germany, October 2-3, 1987.
Drexler HG; Leber BF
Blut; 1988 Mar; 56(3):135-7. PubMed ID: 3128352
[No Abstract] [Full Text] [Related]
3. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
[TBL] [Abstract][Full Text] [Related]
4. Production of transforming growth factor-beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth.
Newcom SR; Kadin ME; Ansari AA
Am J Pathol; 1988 Jun; 131(3):569-77. PubMed ID: 2898211
[TBL] [Abstract][Full Text] [Related]
5. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
6. IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases.
Strauchen JA; Breakstone BA
Am J Pathol; 1987 Mar; 126(3):506-12. PubMed ID: 3103454
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of Hodgkin's disease-derived cell lines.
Tesch H; Jücker M; Falk MH; Bornkamm GW; Jones DB; Diehl V
Hematol Oncol; 1988; 6(3):223-31. PubMed ID: 3136069
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin-2 receptor in childhood non-Hodgkin's lymphoma.
Komp DM; Shapiro E; McNamara J
Blood; 1988 Apr; 71(4):1172-4. PubMed ID: 3128349
[No Abstract] [Full Text] [Related]
10. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
11. Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.
Pizzolo G; Chilosi M; Vinante F; Dazzi F; Lestani M; Perona G; Benedetti F; Todeschini G; Vincenzi C; Trentin L
Br J Cancer; 1987 Apr; 55(4):427-8. PubMed ID: 3107607
[No Abstract] [Full Text] [Related]
12. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
Hsu SM; Xie SS; Hsu PL; Waldron JA
Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
[TBL] [Abstract][Full Text] [Related]
13. Adult non-Hodgkin's lymphoma. Correlation of cell surface marker phenotype with prognosis, the new working formulation, and the Rappaport and Lukes-Collins histomorphologic schemes.
Rudders RA; DeLellis RA; Ahl ET; Bernstein S; Begg CB
Cancer; 1983 Dec; 52(12):2289-99. PubMed ID: 6640501
[TBL] [Abstract][Full Text] [Related]
14. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
15. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
16. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
17. Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukaemia.
Chilosi M; Pizzolo G; Semenzato G; Cetto GL
Int J Biol Markers; 1986; 1(2):101-4. PubMed ID: 3123562
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells.
Heuser C; Guhlke S; Matthies A; Bender H; Barth S; Diehl V; Abken H; Hombach A
Int J Cancer; 2004 Jun; 110(3):386-94. PubMed ID: 15095304
[TBL] [Abstract][Full Text] [Related]
19. Idiotypic immunoglobulin secretion by human B cell non-Hodgkin's lymphomas is related to the expression of the interleukin-2 receptor.
Vyth-Dreese FA; Dellemijn TA; Hekman A; Melief CJ
Leukemia; 1988 Apr; 2(4):231-5. PubMed ID: 3129622
[TBL] [Abstract][Full Text] [Related]
20. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
